Medication Brand Names Beginning with ‘V’, Page 45

Page 45 of 200 « First Page « … 5 10 15 20 25 … 43 44 45 46 47 … 50 55 60 65 70 … » Last Page »

Valsartan and Hydrochlorothiazide

Valsartan and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal…

NuCare Pharmaceuticals,Inc.13 June 2018

Valsartan and Hydrochlorothiazide

Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal…

Actavis Pharma, Inc.23 October 2017

Valsartan and Hydrochlorothiazide

Valsartan and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal…

A-S Medication Solutions22 March 2019

Valsartan and Hydrochlorothiazide

Valsartan and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal…

AvKARE, Inc.14 May 2019

Valsartan and Hydrochlorothiazide

Valsartan and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal…

Denton Pharma, Inc. DBA Northwind Pharmaceuticals31 May 2019

Page 45 of 200 « First Page « … 5 10 15 20 25 … 43 44 45 46 47 … 50 55 60 65 70 … » Last Page »

FDA Medwatch

Surgical Gowns and Packs by Cardinal Health: FDA Statement – Potential Quality Issues Affecting Some of its Level 3 Surgical Gowns and Accompanying PreSource Procedural Packs
Thu, 16 Jan 2020. The medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and accompanying PreSource procedural packs.
FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility
Wed, 15 Jan 2020. FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.